Immobilization of heparin on polysulfone surface for selective adsorption of low-density lipoprotein (LDL)

A versatile method was developed to immobilize heparin covalently on polysulfone sheets (PSu) to achieve selective adsorption of low-density lipoprotein (LDL). This was achieved by activation of PSu with successive treatments of chlorodimethyl ether and ethylenediamine, and subsequent chemical bindi...

Full description

Saved in:
Bibliographic Details
Published inActa biomaterialia Vol. 6; no. 3; pp. 1099 - 1106
Main Authors Huang, Xiao-Jun, Guduru, Deepak, Xu, Zhi-Kang, Vienken, Jörg, Groth, Thomas
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A versatile method was developed to immobilize heparin covalently on polysulfone sheets (PSu) to achieve selective adsorption of low-density lipoprotein (LDL). This was achieved by activation of PSu with successive treatments of chlorodimethyl ether and ethylenediamine, and subsequent chemical binding of heparin with bifunctional linker molecules. A heparin density up to 0.86 μg cm −2 on a dense PSu film was achieved. The modified PSu films were characterized by attenuated total reflectance Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. The hydrophilicity of the PSu film was improved greatly by covalent immobilization of heparin. The water contact angle of PSu film was decreased from 86.6 ± 3.7° to 50.5 ± 3.2° after binding of 0.36 μg cm −2 heparin. An enzyme-linked immunosorbent assay was used to measure the binding of LDL on plain and modified PSu films. It was found that the heparin-modified PSu film could selectively recognize LDL from binary protein solutions. Furthermore, it was possible to desorb LDL from heparinized PSu, but not from plain PSu, with heparin, sodium chloride or urea solution, which indicates a selective but reversible binding of LDL to heparin. The results suggest that heparin-modified PSu membranes are promising for application in simultaneous hemodialysis and LDL apheresis therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1742-7061
1878-7568
DOI:10.1016/j.actbio.2009.08.039